Value
4.2/10data confidence 100%| Component | Sub-score |
|---|---|
| P/E | 4.2 |
| P/S | 4.5 |
| EV/EBITDA | 0.0 |
| Fwd P/E | 5.5 |
| PEG | 4.8 |
| Analyst target | 5.0 |
- ▸Forward P/E: 23.2x
- ▸PEG: 1.65
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Verisk is a high-quality data analytics business with best-in-class 28% margins and positive momentum, but a 22.6x forward P/E, slow growth, 70% insurer customer concentration and only 3.8% upside to the analyst target leave little margin of safety.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
| Pillar | Expectation | Trend |
|---|---|---|
Margins are strong at 28% and the business is rated high-quality, with peer-leading margins and a quality score of 7.8/10. Quality breakdown | Net margin stays above 22% over the next 12 months. | →Stable |
| CounterHigh margins attract competition and rely on proprietary insurance data that large insurers could try to build in-house. | ||
U.S. property and casualty primary insurers account for 70.0% of the customer base, tying results to one industry's budgets and cycle. Bear case | Customer mix diversifies so insurer concentration does not rise above 70%. | →Stable |
| CounterInsurers rely on shared data standards and switching costs are high, so the concentration has been stable and sticky. | ||
The $203.82 analyst target is only 3.8% above the $196.30 price, with a reward-to-risk ratio of 0.26 against 15% downside. Analyst target | Analyst targets are raised well above the current price as growth is confirmed. | ↓Deteriorating |
| CounterAnalyst targets for high-quality compounders tend to lag price, so a thin gap may understate upside. | ||
The stock trades at a forward P/E of 22.6x with a PEG of 1.65 while growth scores only 2.5/10, so the valuation depends on growth accelerating. Valuation breakdown | Earnings growth improves enough to keep the PEG ratio below 1.65 over 12 months. | ↓Deteriorating |
| CounterQuality compounders with recurring subscription revenue often hold premium multiples through slow-growth periods. | ||
The price is above its 200-day average with rising on-balance volume and a momentum score of 7.4/10, supporting trend continuation. Momentum breakdown | The momentum score stays above 5.0 as the uptrend continues. | ↑Improving |
| CounterThe 200-day average slope is flat, and insiders sold about $2.2M with no buys, which could signal a stalled trend. | ||
CounterHigh margins attract competition and rely on proprietary insurance data that large insurers could try to build in-house.
CounterInsurers rely on shared data standards and switching costs are high, so the concentration has been stable and sticky.
CounterAnalyst targets for high-quality compounders tend to lag price, so a thin gap may understate upside.
CounterQuality compounders with recurring subscription revenue often hold premium multiples through slow-growth periods.
CounterThe 200-day average slope is flat, and insiders sold about $2.2M with no buys, which could signal a stalled trend.
| Component | Sub-score |
|---|---|
| P/E | 4.2 |
| P/S | 4.5 |
| EV/EBITDA | 0.0 |
| Fwd P/E | 5.5 |
| PEG | 4.8 |
| Analyst target | 5.0 |
| Component | Sub-score |
|---|---|
| ROA | 10.0 |
| Gross margin | 10.0 |
| Op margin | 10.0 |
| Net margin | 10.0 |
| Current ratio | 4.0 |
| FCF quality | 8.0 |
| Moat | 5.9 |
| Rule of 40 | 5.5 |
| Piotroski F | 6.7 |
| Component | Sub-score |
|---|---|
| Rev growth | 3.6 |
| EPS growth | 1.3 |
| Component | Sub-score |
|---|---|
| RSI | 5.0 |
| MACD | 10.0 |
| OBV | 10.0 |
| MA position | 8.0 |
| Volume | 1.9 |
| Component | Sub-score |
|---|---|
| Analyst rating | 7.4 |
| Price target | 7.1 |
| erm sentiment | 5.0 |
| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 2.8 |
| notable moves | 3.0 |
| Component | Sub-score |
|---|---|
| value rank | 1.2 |
| quality rank | 8.8 |
| growth rank | 3.3 |
| Component | Sub-score |
|---|---|
| bollinger | 2.7 |
| support resistance | 1.8 |
| 52w position | 5.7 |
| gap | 6.0 |
| Component | Sub-score |
|---|---|
| short interest | 8.0 |
| days to cover | 7.3 |
| volatility | 3.2 |
| put call | 10.0 |
| implied vol | 3.8 |
| max pain risk | 3.0 |
| beta | 9.0 |
| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 10.0 |
| earnings timing | 5.0 |
| surprise avg | 5.1 |
| dividend safety | 8.5 |
Multiple concerning factors. Consider reducing position.
L4:PATH_F_SELLSetupMomentum Cont — Trend continuation, RSI 64, MACD bullish
EdgeNo clear edge — No clear edge identified
SuitabilityModerate — Balanced profile
The F-path SELL output reflects an overall score of 4.7 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Quality at 7.8) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( ASYMMETRY:0.2<1.5@spot, EARNINGS_PROXIMITY:2d<=7d) reinforce the read. Current asymmetry R:R is 0.23 — supplementary context, not the trigger for this path.
The strongest dimensions are Quality at 7.8, Momentum at 7.0, and Catalyst at 6.7; the weakest are Growth at 2.5, Insider at 3.6, and Technical at 4.0. The V9 engine flagged 2 failed gates with 1 warning, producing an asymmetric reward-to-risk of 0.23 and an engine sizing output of AVOID.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
Trip ifNet margin falls below 22% from the current 28%.
Trip ifP&C insurer customer share falls below 60% from the current 70.0%.
Trip ifAnalyst target rises above $230 from the current $203.82.
Trip ifForward P/E exceeds 26x from the current 22.6x without matching earnings growth.
Trip ifMomentum score falls below 5.0 from the current 7.4.